Trial Profile
An open clinical study of high-dose (6 mg/kg tid) cefditoren pivoxil in children with bacterial pneumonia, acute otitis media and acute rhinosinusitis (Phase III)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Cefditoren pivoxil (Primary)
- Indications Bacterial infections; Otitis media; Pneumonia; Rhinosinusitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Meiji Seika Pharma
- 20 May 2016 New trial record